Results 1 to 10 of about 18,748 (103)

Improving Visual Comfort during Computer Gaming with Preservative-Free Hyaluronic Acid Artificial Tears Added to Ergophthalmological Measures [PDF]

open access: yesVision (Switzerland), 2023
Digital asthenopia (DA) or Computer Vision Syndrome can occur after prolonged use of digital devices and is usually managed with ergophthalmological measures and the use of artificial tears.
Peris-Martinez C
exaly   +4 more sources

Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections [PDF]

open access: yesClinical Ophthalmology, 2022
Francisco Pastor-Pascual,1 Rafael Pastor-Pascual,1 Patricia Gálvez-Perez,1 Rosa Dolz-Marco,2 Roberto Gallego-Pinazo2 1Anterior Segment Department, Valencia, Spain; 2Posterior Segment Department, Valencia, SpainCorrespondence: Francisco Pastor-Pascual ...
Pastor-Pascual F   +4 more
exaly   +4 more sources

Artificial tears: Promising treatment or silent threat to public health? [PDF]

open access: yesHealth Science Reports, 2023
Background and Aims Dry Eye Disease (DED) is a multifactorial chronic inflammatory condition of the corneal surface, attributed to insufficient or low‐quality production of tears, accounting for 5‐50% of the cases globally. Artificial tears are the first
Sanila Mughal, Syeda K. Sakina
doaj   +2 more sources

Artificial Tears: A Systematic Review [PDF]

open access: yesClinical Optometry, 2023
David A Semp, Danielle Beeson, Amy L Sheppard, Debarun Dutta, James S Wolffsohn School of Optometry, College of Health and Life Sciences, Aston University, Birmingham, UKCorrespondence: James S Wolffsohn, Tel +44 121 2044140, Email j.s.w.wolffsohn@aston ...
Semp DA   +4 more
doaj   +2 more sources

Personalized Management of Dry Eye Disease: Beyond Artificial Tears [PDF]

open access: yesClinical Ophthalmology, 2022
Cynthia Matossian,1,2 Micaela Crowley,3 Laura Periman,4 Steven Sorkin5 1Matossian Eye Associates, Pennington, NJ, USA; 2Matossian Eye Associates, Doylestown, PA, USA; 3Lexington Eye Associates, Lexington, MA, USA; 4Periman Eye Institute, Seattle, WA, USA;
Matossian C   +3 more
doaj   +2 more sources

Control System Applied to the Microinjection of Artificial Tears for Severe Dry Eye Treatment

open access: yesApplied Sciences (Switzerland), 2020
This paper presents a portable automated teardrop microinjection system as a practical solution for patients suffering from severe dry eye. The electronic device for the controlled and continuous injection of artificial tears is designed, assembled, and ...
Narcisse Meni Babakidi   +2 more
exaly   +3 more sources

Management of Dry Eye Disease with Artificial Tears Containing Hyaluronic Acid and Trehalose: A Narrative Review [PDF]

open access: yesClinical Ophthalmology
Melissa Barnett,1 Michelle K Rhee,2 Kendall E Donaldson3 1Baker Optometry or Alpine Blue, Davis, CA, USA; 2Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 3Bascom Palmer Eye Institute of Plantation, Plantation, FL,
Barnett M, Rhee MK, Donaldson KE
doaj   +2 more sources

Safety and efficacy of rebamipide compared to artificial tears for the treatment of dry eye: a systematic review and meta-analysis [PDF]

open access: yesBMC Ophthalmology
Background Rebamipide (RBM) is a novel drug that increases mucin secretion on the ocular surface. Nevertheless, the therapeutic efficacy of topical RBM for dry eye disease (DED) treatment remains inconclusive.
Ching-Wen Chiu, Ka-Wai Tam, I-Chan Lin
doaj   +2 more sources

Effects of artificial tears on ocular surface symptoms and visual task performance in digital device users [PDF]

open access: yesScientific Reports
This prospective, single-arm study investigates the effects of preservative-free artificial tears on ocular symptoms, visual task performance, and tear film stability in visual display terminal (VDT) users.
Sara Ortiz-Toquero   +2 more
doaj   +2 more sources

Comparative Efficacy of Platelet-Rich Plasma, Autologous Serum, and Artificial Tears in Dry Eye Disease: A Systematic Review and Meta-Analysis [PDF]

open access: yesBiomedicines
Background/Objectives: Dry eye disease (DED) is a prevalent, complex disorder with a major impact on patients’ quality of life. While artificial tears (AT) are still the first-line treatment, their effectiveness is often limited in moderate-to-severe ...
Alexandra Laura Mederle   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy